Jonathan Male originally joined PNNL in 2006 as a scientist focused on catalysis. After more than seven years leading DOE’s Bioenergy Technologies Office, he's back at PNNL as a chief scientist in the Energy Processes & Materials Division.

PNNL computational biologist Bobbie-Jo Webb-Robertson was recently awarded the “Spirit of nPOD award” to acknowledge her hard work in building, coordinating, and leading the Data Science Working Group.

To help spur economic development and assist in the battle against COVID-19, PNNL is making available its entire portfolio of patented technologies on a research trial basis—at no cost—through the end of 2020.

PNNL biomedical scientist Ernesto Nakayasu brings expertise in host-pathogen interactions and the interconnection between the immune response and cellular metabolism to provide constructive review for submitted manuscripts.

After 50 years in science and on the eve of retirement, Laboratory Fellow Karin Rodland, a cancer cell biologist at PNNL, is working on experiments she has dreamed about for decades.

Accurate identification of metabolites, and other small chemicals, in biological and environmental samples has historically fallen short when using traditional methods.

A long-standing collaboration between PNNL and Oregon State University to study harmful chemicals at federally designated hazardous waste sites primarily across the Pacific Northwest has been awarded a five-year, $12.7 million grant.

A new study using proteogenomics to compare cancerous tissue with normal fallopian tube samples advances insights about the molecular machinery that underlies ovarian cancer.

The recent coronavirus pandemic shows just how quickly a deadly pathogen can sweep across the globe, killing tens of thousands in the U.S. and disrupting daily life for millions more in the span of a few months.

Artificial intelligence helps researchers identify metabolites, the small molecules that underlie life.

Dr. Xiao-Ying Yu, a physical chemist at PNNL, was recently invited to join the editorial board of Atmosphere, an international peer-reviewed journal that publishes work related to—you guessed it—the atmosphere.

A PNNL scientist is studying the structures of the proteins on the surface of the novel coronavirus, using NMR spectroscopy to reveal information about the molecular toolkit that holds the keys to a vaccine or treatment.

The race toward the first practical quantum computer is in full stride. Scientists at PNNL are bridging the gap between today’s fastest computers and tomorrow’s even faster quantum computers.

A chemical engineer by day at PNNL, Dan Howe is an ardent home brewer by night. The connection resulted in production of biocrude oil from brewery waste.

Combining its strength in biological sciences and data analytics, researchers at the Department of Energy's PNNL are working to enable a quick response to a biological incident — whether intentional, accidental or natural.

Shannon Stahl leads the Molecular Mediators thrust in the Center for Molecular Electrocatalysis (CME). Stahl Is the winner of the 2020 American Chemical Society Catalysis Lectureship.

PNNL researchers and professional staff led discussions ranging from biothreats and climate change to science careers at the 2020 annual meeting of the American Association for the Advancement of Science, held this year in Seattle.

A new study focusing on the proteins involved in endometrial cancer, commonly known as uterine cancer, offers insights about which patients will need aggressive treatment and which won’t.

The researchers treated human pancreatic islets with substances produced by the body and thought to be involved in the diabetes disease process.

While it’s one small step forward for mouse research, it’s a big step forward for understanding proteins, the molecular workhorses in biological organisms.